12:00 AM
 | 
Nov 12, 2012
 |  BC Week In Review  |  Company News  |  Deals

NeuroNova, Newron deal

Newron will acquire neurogenesis company NeuroNova in an amended stock deal valuing NeuroNova at €15.5 million ($20 million). NeuroNova shareholders will be issued 2.4 million shares of Newron, representing a...

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >